4RY-20234-67908
2 vaccinations
4 coded responses
11 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 277 / NC
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Good · Site: Pain · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 9 hours after I received my shot, the left side of my face went numb and lasted for 24 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-21
- 2021-01-30
- 2021-02-04
- 2021-02-25
- 2021-03-24
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Erythema, Eye swelling, Lip swelling, Ocular hyperaemia, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continue to have lip swelling and red patches on face. Started with eyes swelling and red in March. Now on Methyltrexate. See and allergist and dermatologist and still do not know if cause was vaccine as seems to be affecting the nervesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-15
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-20
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Hypoaesthesia, Lip swelling, Swelling face — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: On-going facial numbness with occasional lip and face swelling. I am now on MethytrexateMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-18
- 2022-01-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): None
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): 9 hours after I received my shot, the left side of my face went numb and lasted for 24 hours
Release 9 — 6 months, dose 2
Symptoms: Continue to have lip swelling and red patches on face. Started with eyes swelling and red in March. Now on Methyltrexate. See and allergist and dermatologist and still do not know if cause was vaccine as seems to be affecting the nerves
Release 10 — 12 months, dose 2
Symptoms: On-going facial numbness with occasional lip and face swelling. I am now on Methytrexate
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Erythema | ✓ | · | ✓ |
| SD | Eye swelling | ✓ | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Lip swelling | ✓ | · | ✓ |
| SD | Ocular hyperaemia | ✓ | · | ✓ |
| SD | Office visit | ✓ | · | ✓ |
| SD | Swelling face | · | · | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release